Latest Articles
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer OncLive
Published: Oct. 15, 2025, 5:46 p.m.
Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer - OncLive
Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer OncLive
Published: Oct. 15, 2025, 12:10 p.m.
Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog - FMIBlog
Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog FMIBlog
Published: Oct. 15, 2025, 6:44 a.m.
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com
Published: Oct. 14, 2025, 6:39 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 4:49 p.m.
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer Nature
Published: Oct. 14, 2025, 4:47 p.m.
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer
Published: Oct. 14, 2025, 2:41 p.m.
Jackie Burch dead: Breakfast Club and Die Hard legend dies after endometrial cancer battle - The Mirror
Jackie Burch dead: Breakfast Club and Die Hard legend dies after endometrial cancer battle The Mirror
Published: Oct. 14, 2025, 8:42 a.m.
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer - CancerNetwork
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer CancerNetwork
Published: Oct. 13, 2025, 10:05 p.m.
Link copied to clipboard!